Cuba participates in international forum on medical cooperation in China

HAVANA, Cuba, May 27 (ACN) Cuba participates in a Shanghai Cooperation Organization (SCO) international forum meeting in the Zhuang autonomous region of Guangxi, southern China, to discuss medical innovation and collaboration.

Prensa Latina news agency reports from Beijing that the island is represented by Yamira Palacios, head of the Marketing Office of Cuban Medical Services S.A. and the Medical Brigade in China.

Palacios stated that the program contemplates the debate in committees on topics such as the need to cooperate to improve the quality of health services.

Other issues to be addressed are to take advantage of the strengths of each territory, encourage the exchange of experiences in academic training, at the scientific level and in research, she added.

The deliberations -she specified- include the strengthening of primary health care as the main axis of disease prevention, and the exploration of ways to share technologies and train new specialists in cardiology, surgery, orthopedics, pharmaceutical industry and biotechnology.

Also, Palacios met with Huang Wenxi, director of the International Department of the Zhuang Health Commission of Guangxi, and other Guangxi authorities who expressed the will to hire Cuban specialists, train some on the Caribbean island and administer their biotechnology products.

They discussed how to expand cooperation in oncology in cases such as nasopharyngeal carcinoma and the application of the vaccine against lung cancer, with high incidence in the Chinese population.

In the latter case specifically, Cuba successfully developed the first therapeutic vaccine in history to treat this disease, and it is increasingly accepted worldwide.

The SCO event runs from May 26-29 in the coastal city of Fangchenggang and also brings together delegates from states such as Russia, India, Belarus, Afghanistan, Nepal, Ukraine, Philippines, Turkey, Cambodia, Sir Lanka, Tajikistan and Kazakhstan, among others.

In addition, senior officials from the Chinese government, medical and research institutions, as well as pharmaceutical companies from various nations and international organizations attend.